(2021)
Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society.
ENDOCRINOLOGY AND METABOLISM.
36,
4
(2021)
Fracture recurrence in hip fracture with menopausal hormone therapy versus risedronate: a clinical trial.
CLIMACTERIC.
24,
4
(2021)
Comparison of Four Ultrasonography-Based Risk Stratification Systems in Thyroid Nodules with Nondiagnostic/Unsatisfactory Cytology: A Real-World Study.
CANCERS.
13,
8
(2021)
Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study.
ENDOCRINOLOGY AND METABOLISM.
36,
1
(2019)
High circulating follistatin-like protein 1 as a biomarker of a metabolically unhealthy state.
ENDOCRINE JOURNAL.
66,
3
(2019)
Assessment of patient-reported outcomes (PROs): treatment satisfaction, medication adherence, and quality of life (QoL) and the associated factors in postmenopausal osteoporosis (PMO) patients in Korea.
JOURNAL OF BONE AND MINERAL METABOLISM.
37,
3
(2018)
Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area.
EUROPEAN JOURNAL OF NUTRITION.
57,
2
(2017)
Impact of gastrointestinal events on patient-reported outcomes in Asia-Pacific women with osteoporosis: baseline results of the MUSIC OS-AP study.
ARCHIVES OF OSTEOPOROSIS.
12,
1
(2017)
Novel 4-bp Intronic Deletion (c.1560+3_1560+6del) in LEMD3 in a Korean Patient With Osteopoikilosis.
ANNALS OF LABORATORY MEDICINE.
37,
6
(2017)
Hormetic effect of triiodothyronine in metabolically healthy obese persons.
ENDOCRINE.
57,
3
(2017)
Subclinical thyroid dysfunction and risk of carotid atherosclerosis.
PLOS ONE.
12,
7
(2017)
Association of triiodothyronine levels with future development of metabolic syndrome in euthyroid middle-aged subjects: a 6-year retrospective longitudinal study.
EUROPEAN JOURNAL OF ENDOCRINOLOGY.
176,
4
(2017)
Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis.
OSTEOPOROSIS INTERNATIONAL.
28,
4
(2017)
Strong association of relatively low and extremely excessive iodine intakes with thyroid cancer in an iodine-replete area.
EUROPEAN JOURNAL OF NUTRITION.
56,
3
(2017)
Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women.
OSTEOPOROSIS INTERNATIONAL.
28,
3
(2016)
Low Plasma Level of Leucine-Rich Repeat-Containing 17 (LRRc17) Is an Independent and Additive Risk Factor for Osteoporotic Fractures in Postmenopausal Women.
JOURNAL OF BONE AND MINERAL RESEARCH.
31,
12
(2016)
Pharmacologic treatment of osteoporosis.
대한의사협회지.
59,
11
(2016)
Decreased Plasma Levels of Sclerostin But Not Dickkopf-1 are Associated with an Increased Prevalence of Osteoporotic Fracture and Lower Bone Mineral Density in Postmenopausal Korean Women.
CALCIFIED TISSUE INTERNATIONAL.
99,
4
(2016)
Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label Extension.
YONSEI MEDICAL JOURNAL.
57,
4
(2016)
Vitamin D Repletion in Korean Postmenopausal Women with Osteoporosis.
YONSEI MEDICAL JOURNAL.
57,
4
단행본
(2020)
골다공증 진료지침 2020.
인벤터스.
공동
(2019)
골다공증 진료지침 2019.
씨대엠더빅.
공동
(2018)
골다공증 진료지침 2018.
씨디엠더빅.
공동
(2016)
임상 내분비학 3판.
도서출판 고려의학.
공동
(2016)
골다공증 (Text of Osteoporosis).
군자출판사.
공동
(2015)
골다공증의 진단 및 치료 지침 2015.
아이비기획.
공동
(2015)
노인병학 제3판.
범문에듀케이션.
공동
(2013)
골다공증
Textbook of Osteoporosis.
군자출판사.
공동
(2013)
골다공증의 진단 및 치료 지침2013.
아이비기획.
공동
(2011)
골다공증의 진단 및 치료 지침 2011.
민컴.
공동
(2011)
내분비대사학.
군자출판사.
공동
(2008)
골다공증 진단 및 치료 지침 2008.
서흥출판사.
공동
(2007)
골다공증 진단 및 치료 지침 2007.
서흥출판사.
공동
(2007)
골다공증(임상의를 위한 골다공증의 가이드 진단.예방 및 치료).
청운.
공동
(2006)
내분비학 용어집.
군자출판사.
공동
(2006)
성공노화 : 유전자, 호르몬, 생활습관.
도서출판 의학출판사.
공동
(2006)
골다공증.
도서출판 한미의학.
공동
(2005)
노인병학.
도서출판 의학출판사.
공동
(2004)
골다공증 치료 지침서.
서흥출판사.
공동
(2004)
임상내과학.
고려의학.
공동
학술회의논문
(2020)
골다공증 최신 지견.
2020 공공기관 재직의사 추계 만성질환 워크숍.
대한민국
(2020)
골다공증 치료.
2020 공공기관 재직의사 춘계 학술대회.
대한민국
(2020)
Food for thought on HRT for osteoporosis.
2020 대한골대사학회 제4차 골대사질환 심화과정.
대한민국
(2019)
Bisphosphonate 50th anniversary: New insights into an old story.
2019 대한골대사학회 제31차 추계학술대회.
대한민국
(2019)
골다공증 치료.
2019 공공기관 재직의사 추계 학술대회.
대한민국
(2019)
골다공증 치료제 Update.
부울경내분비대사학회 정기 집담회.
대한민국
(2019)
Pre-and Post-Era of bisphosphonate therapy in Korea.
2019 THE 7TH SEOUL STMPOSIUM ON BONE HEALTH.
대한민국
(2019)
Hormone replacement therapy and osteoporosis.
2019 THE 7TH SEOUL STMPOSIUM ON BONE HEALTH.
대한민국
(2019)
골다공증 치료제 Update.
2019 공공기관 재직의사 춘계 학술대회.
대한민국
(2018)
Clinical Tip for Selection of Osteoporosis Medication (Including Drug Holiday Issue).
2018년도 제67차 대한통증학회 학술대회 및 연수교육.
대한민국
(2018)
골대사 : Osteoporosis : The past 30 years.
Endocrine Week 2018.
대한민국
(2018)
Medications and other injections for osteoporosis.
제6회 가톨릭대학교 의과대학 마취통증의학교실 심포지엄.
대한민국
(2017)
골다공증의 최신지견.
2017 공공기관 재직의사 추계 워크숍.
대한민국
(2017)
Factors associated with medication adherence in Korean postmenopausal osteoporosis(PMO) patients: Results from PMO Outcomes Research.
ISPOR 20th Annual European Congress.
영국
(2017)
Bone 2017.
대한내분비학회 대사성골질환연구회 2017 심포지엄.
대한민국
(2017)
Treatment of osteoporosis.
2017년도 대한통증학회 약물치료 연수강좌.
대한민국